Related Experiment Video
Updated: Jan 26, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Global Reduction of H3K4me3 Improves Chemotherapeutic Efficacy for Pediatric Ependymomas
Rebecca Lewis1, Yuping D Li1, Lindsey Hoffman2
1Falk Brain Tumor Center and Division of Pediatric Neurosurgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Background:
Ependymomas (EPNs) are the third most common brain tumor in children. These tumors are resistant to available chemotherapeutic treatments, therefore new effective targeted therapeutics must be identified. Increasing evidence shows epigenetic alterations including histone posttranslational modifications (PTMs), are associated with malignancy, chemotherapeutic resistance and prognosis for pediatric EPNs. In this study we examined histone PTMs in EPNs and identified potential targets to improve chemotherapeutic efficacy.
Methods:
Global histone H3 lysine 4 trimethylation (H3K4me3) levels were detected in pediatric EPN tumor samples with immunohistochemistry and immunoblots. Candidate genes conferring therapeutic resistance were profiled in pediatric EPN tumor samples with micro-array. Promoter H3K4me3 was examined for two candidate genes, CCND1 and ERBB2, with chromatin-immunoprecipitation coupled with real-time PCR (ChIP-PCR). These methods and MTS assay were used to verify a relationship between H3K4me3 levels and CCND1 and ERBB2, and to investigate cell viability in response to chemotherapeutic drugs in primary cultured pediatric EPN cells.
Results:
H3K4me3 levels positively correlate with WHO grade malignancy in pediatric EPNs and are associated with progression free survival in patients with posterior fossa group A EPNs (PF-EPN-A). Reduction of H3K4me3 by silencing its methyltransferase SETD1A, in primary cultured EPN cells increased cell response to chemotherapy.
Conclusions:
Our results support the development of a novel treatment that targets H3K4me3 to increase chemotherapeutic efficacy in pediatric PF-EPN-A tumors.
Insights
Targeting histone trimethylation (H3K4me3) may improve chemotherapy for pediatric ependymomas (EPNs). Reducing H3K4me3 levels enhanced treatment response in EPN cells, suggesting a new therapeutic strategy.
Area of Science:
- Pediatric oncology
- Epigenetics
- Molecular biology
Background:
- Ependymomas (EPNs) are common pediatric brain tumors.
- EPNs exhibit resistance to current chemotherapies.
- Epigenetic alterations, including histone posttranslational modifications (PTMs), are linked to EPN malignancy and treatment resistance.
Purpose of the Study:
- To investigate the role of histone PTMs in pediatric EPNs.
- To identify potential therapeutic targets for improving chemotherapy efficacy in EPNs.
Main Methods:
- Quantified global histone H3 lysine 4 trimethylation (H3K4me3) in pediatric EPN samples.
- Analyzed candidate genes (CCND1, ERBB2) associated with therapeutic resistance.
- Utilized chromatin-immunoprecipitation coupled with real-time PCR (ChIP-PCR) to examine promoter H3K4me3.
- Assessed cell viability and chemotherapy response in primary EPN cells.
Main Results:
- H3K4me3 levels positively correlate with tumor grade and impact progression-free survival in posterior fossa group A EPNs (PF-EPN-A).
- Silencing the H3K4me3 methyltransferase SETD1A increased EPN cell sensitivity to chemotherapy.
Conclusions:
- H3K4me3 is a potential biomarker for pediatric EPNs.
- Targeting H3K4me3 may enhance chemotherapeutic efficacy, particularly for PF-EPN-A tumors.
More Related Videos
03:37Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry
Published on: June 6, 2025
13:06Improved In-gel Reductive β-Elimination for Comprehensive O-linked and Sulfo-glycomics by Mass Spectrometry
Published on: November 20, 2014
Related Concept Videos
Global Climate Change
Oxidation-Reduction Reactions
Self-Efficacy
Introduction to Global Positioning System
Global Regulatory Systems
Errors in Global Positioning System